Psicofarma S.A. de C.V. is a 100% Mexican pharmaceutical company founded in 1974 by a group of psychiatrists dedicated to serving patients with mental health conditions. It specializes in treatments for the central nervous system (CNS) and holds a leading position in the CNS prescription market in Mexico. The company also develops products in hospital care, metabolic syndrome, and pain management. It manufactures safe and effective medicines under Good Manufacturing Practices and invests in research and development of new therapeutic options.
| Import | Export |
|---|---|
|
Trade Records
235
|
Trade Records
120
|
|
Suppliers
20
|
Buyers
19
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, PSICOFARMA S.A. DE C.V. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the PSICOFARMA S.A. DE C.V. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, PSICOFARMA S.A. DE C.V. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore PSICOFARMA S.A. DE C.V.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | PSICOFARMA S.A. DE C.V. | 2915 | 24 | $186,500 | 3,420 | Los Angeles |
| CHEMO S A LUGANO BRANCH | PSICOFARMA S.A. DE C.V. | 2921 | 24 | $186,500 | 3,420 | Los Angeles |
| IMA INDUSTRIA MACCHINE AUTOMATICHE SPA | PSICOFARMA S.A. DE C.V. | 8479 | 24 | $186,500 | 3,420 | Los Angeles |
| BONFIGLIOLI ENGINEERING S R I S U | PSICOFARMA S.A. DE C.V. | 9031 | 24 | $186,500 | 3,420 | Los Angeles |
| TAPI NL B V | PSICOFARMA S.A. DE C.V. | 2933 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into PSICOFARMA S.A. DE C.V.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| AGENCIAS CELMAR | PSICOFARMA S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| CASA DE REPRESENTACIONES FARMACEUTICAS CCM | PSICOFARMA S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| PSICOFARMA S.A. | PSICOFARMA S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| AMEX EXPORT-IMPORT GESMBH | PSICOFARMA S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| NEOLPHARMA PERU SOCIEDAD ANONIMA CERRADA-NEOLPHARMA PERU S.A.C. | PSICOFARMA S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore PSICOFARMA S.A. DE C.V.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access PSICOFARMA S.A. DE C.V.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.